Yabe, Hiroki https://orcid.org/0000-0002-0444-6830
Okada, Keiko
Kono, Kenichi
Imoto, Yuto
Onoyama, Ayaka
Ito, Sayaka
Moriyama, Yoshifumi
Kasuga, Hirotake
Ito, Yasuhiko
Funding for this research was provided by:
Kaken Pharmaceutical
Article History
Received: 18 July 2022
Accepted: 7 December 2022
First Online: 23 December 2022
Declarations
:
: The co-author (YI) has received honoraria from Baxter and research funding from Kyowa-Kirin, Chugai, and Baxter.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval No. 16064) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in this study.
: This study was prospectively registered at inception in the UMIN Clinical Trials Registry (Identification No. UMIN000038405).